Etidocaine
- CAS NO.:36637-18-0
- Empirical Formula: C17H28N2O
- Molecular Weight: 276.42
- MDL number: MFCD00835366
- EINECS: 253-143-8
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-03-13 23:13:44
What is Etidocaine?
Originator
Duranest,Astra,US,1976
The Uses of Etidocaine
Anesthetic (local).
Background
Etidocaine is marketed under the name Duranest. It is an injectable local anesthetic during surgery, labor, and delivery. Etidocaine has a long duration of activity, but has the main disadvantage of increased bleeding during oral surgery.
Definition
ChEBI: An amino acid amide in which 2-[ethyl(propyl)amino]butanoic acid and 2,6-dimethylaniline have combined to form the amide bond. Used as a local anaesthetic (amide caine), it has rapid onset and long action properties, similar to bupivacaine, and is given b injection during surgical procedures and during labour and delivery.
Manufacturing Process
α-(n-Propylamino)-n-butyro-2,6-xylidide(0.243 mol) and freshly distilled diethyl sulfate (1.6 mols were mixed in a flask equipped with reflux condenser, drying tube and stirrer. The mixture was stirred for 5 hours at 90°C. After cooling, water (110 ml) was added with stirring for 15 minutes followed by 4M HCl (110 ml). The solution was washed with ether (3 X 100 ml) and made alkaline with 7M NaOH to pH 10-11. The freed base was taken up in ether (3 X 100 ml); the extracts were dried over sodium sulfate, filtered and evaporated. The residue was dissolved in absolute ether (200 ml) and the hydrochloride prepared by addition of ethereal hydrogen chloride. The precipitate was filtered, washed with ether, and recrystallized twice from absolute ethanol/ether and from isopropanol/isopropylether; MP 203°C to 203.5°C; yield: 0.126 mol (52%). The starting material is prepared by reacting 2-bromobutyric acid with sulfonyl chloride to give the acid chloride. It is then reacted with 2,6-xylidine, then with potassium iodide followed by n-propylamine.
brand name
Duranest [as hydrochloride] (Astra).
Therapeutic Function
Local anesthetic
Metabolism
Not Available
Properties of Etidocaine
| Boiling point: | 389.7±30.0 °C(Predicted) |
| Density | 0.993±0.06 g/cm3(Predicted) |
| pka | 14.18±0.70(Predicted) |
Safety information for Etidocaine
Computed Descriptors for Etidocaine
New Products
2-(2-aminoethyl) benzenesulfonamide Gemcitabine 3-benzoate impurity Dihydroxyphenylacetone Ornidazole EP impurity D Acetyl amino diol impurity Valsartan Benzyl Ester Impurity B N,N'-Dicyclohexylcarbodiimide 3-Bromo-2-Methyl-5-Nitropyridine 5-Bromo-3-Methyl-2-Pyridinecarboxylic acid 2-Amino-4-Methylpyridine 4-Aminopyridine 4-dimethylaminopyridineRelated products of tetrahydrofuran




![N-BENZYL-N-{1-[(2,6-DIMETHYLANILINO)CARBONYL]CYCLOHEXYL}-5-OXO-2-PYRROLIDINECARBOXAMIDE](https://img.chemicalbook.in/StructureFile/ChemBookStructure4/GIF/CB6139265.gif)

![N-{1-[(2,6-DIMETHYLANILINO)CARBONYL]CYCLOHEXYL}-N-(2-FURYLMETHYL)-5-OXO-2-PYRROLIDINECARBOXAMIDE](https://img.chemicalbook.in/StructureFile/ChemBookStructure4/GIF/CB0190501.gif)

You may like
-
4-(Methylnitrosoamino)-butanal NLT 95%View Details
339362-86-6 -
848696-99-1 NLT 95%View Details
848696-99-1 -
Ornidazole EP impurity A 1384752-15-1 NLT 95%View Details
1384752-15-1 -
615-81-6 Diisopropyl oxalate NLT 95%View Details
615-81-6 -
175481-38-6 Lacosamide EP Impurity F NLT 95%View Details
175481-38-6 -
S-Clopidogrel N-Methyl Impurity 1346605-15-9 NLT 95%View Details
1346605-15-9 -
Valsartan Related Compound A NLT 95%View Details
137862-87-4 -
Losartan Propyl BCFI 124750-49-8 NLT 95%View Details
124750-49-8
